Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Gaceta Medica De Mexico|January 16, 2004
[Analysis of Bcr-abl type transcript and its relationship with platelet count in Mexican patients with chronic myeloid leukemia]Alejandro Rosas-Cabral, Manuel Martínez-Mancilla, Manuel Ayala-Sánchez, et al.
Nanomaterials (Basel, Switzerland)|June 2, 2021
On the Thermal Models for Resistive Random Access Memory Circuit SimulationJuan B Roldán, Gerardo González-Cordero, Rodrigo Picos, et al.
Nature Nanotechnology|October 28, 2025
A quantum resistance memristor for an intrinsically traceable International System of Units standardGianluca Milano, Xin Zheng, Fabio Michieletti, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|October 1, 2003
[National evaluation of the diagnosis of activated protein C resistance]Guadalupe Montiel-Manzano, Aurora de la Peña-Díaz, Abraham Majluf-Cruz, et al.
Nature Communications|March 4, 2024
Hardware implementation of memristor-based artificial neural networksFernando Aguirre, Abu Sebastian, Manuel Le Gallo, et al.
Immunity|April 16, 2017
Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established TumorsFrederick Arce Vargas, Andrew J S Furness, Isabelle Solomon, et al.
ACS Nano|November 3, 2021
Standards for the Characterization of Endurance in Resistive Switching DevicesMario Lanza, Rainer Waser, Daniele Ielmini, et al.
Biomed Research International|February 19, 2015
Prevalence of gene rearrangements in Mexican children with acute lymphoblastic leukemia: a population study-report from the Mexican Interinstitutional Group for the identification of the causes of childhood leukemiaVilma Carolina Bekker-Méndez, Enrique Miranda-Peralta, Juan Carlos Núñez-Enríquez, et al.
Immunity|April 25, 2025
Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodiesFelipe Galvez-Cancino, Mariela Navarrete, Gordon Beattie, et al.
Pageof 5